News
Read up on the latest
news from BioReperia
Explore our latest news articles on how our contract research organization accelerates pre-clinical drug development.
New publication: ZTX® in vivo data contribute to the preclinical evaluation of Telomir-Zn in triple-negative breast cancer
12 August 2026 /
3R
BioReperia
Pressrelease
Publications
Zebrafish PDX
BioReperia Announces New Leadership Appointments
18 March 2026 /
BioReperia
Pressrelease
BioReperia Presents ASCO Poster Showcasing the ZTX® Platform for Late Preclinical Drug Development
20 October 2025 /
Pressrelease
Zebrafish PDX
BioReperia provides key in vivo validation in AML study published in Leukemia
27 June 2025 /
Pressrelease
Zebrafish PDX
FDA Announces Shift Away from Mandatory Animal Testing – BioReperia Offers a Validated, Human-Relevant Alternative
16 April 2025 /
3R
Zebrafish PDX
BioReperia represented at Tumor Models Nordics
15 April 2025 /
BioReperia
Conferences and meetings
Pros and cons of the ZTX model
23 September 2022 /
Uncategorized
New article published
23 February 2022 /
Zebrafish PDX
Zebrafish predict treatment in lungcancer
23 February 2022 /
Zebrafish PDX
Join BioReperias FREE webinars
31 August 2021 /
Uncategorized
The 50 “companies-for-the-future” this year – BioReperia is one of the finalists in Techarenan Challenge 2021!
9 June 2021 /
Uncategorized
Job opening
18 December 2020 /
Uncategorized